3 4 The Chinese Center for Disease Control and Prevention reported that the incidence was showing an increasing trend, with an estimated 200 000 new cases annually from 2014 to 2018.
← all excerpts
Cost-utility of sofosbuvir/velpatasvir versus other direct-acting antivirals for chronic hepatitis C genotype 1b infection in China.
1
—
—